Overview

LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study

Status:
Terminated

Trial end date:
2015-03-01

Target enrollment:

Participant gender:

Summary

LUXSOL Cream may be useful for the treatment of bacterial Vaginosis. In this study, LUXSOL Cream is compared to a control arm group using metronidazole cream. LUXSOL is administered intravaginally for 10 days, each evening before bedtime to treat bacterial Vaginosis..

Phase:

Early Phase 1

Details

Lead Sponsor:

CDA Research Group, Inc.

Treatments:

Copper
Metronidazole